4.4 Review

Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness

期刊

MOLECULAR BRAIN
卷 4, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1756-6606-4-21

关键词

-

资金

  1. Canadian Institutes of Health Research (CIHR)
  2. Canadian Psychiatric Research Foundation
  3. Heart and Stroke Foundation Centre for Stroke Recovery
  4. Ontario Mental Health Foundation
  5. CIHR

向作者/读者索取更多资源

The serotonin-1A (5-HT1A) receptor is among the most abundant and widely distributed 5-HT receptors in the brain, but is also expressed on serotonin neurons as an autoreceptor where it plays a critical role in regulating the activity of the entire serotonin system. Over-expression of the 5-HT1A autoreceptor has been implicated in reducing serotonergic neurotransmission, and is associated with major depression and suicide. Extensive characterization of the transcriptional regulation of the 5-HT1A gene (HTR1A) using cell culture systems has revealed a GC-rich housekeeping promoter that non-selectively drives its expression; this is flanked by a series of upstream repressor elements for REST, Freud-1/CC2D1A and Freud-2/CC2D1B factors that not only restrict its expression to neurons, but may also regulate the level of expression of 5-HT1A receptors in various subsets of neurons, including serotonergic neurons. A separate set of allele-specific factors, including Deaf1, Hes1 and Hes5 repress at the HTR1A C(-1019) G (rs6295) polymorphism in serotonergic neurons in culture, as well as in vivo. Pet1, an obligatory enhancer for serotonergic differentiation, has been identified as a potent activator of 5-HT1A autoreceptor expression. Taken together, these results highlight an integrated regulation of 5-HT1A autoreceptors that differs in several aspects from regulation of post-synaptic 5-HT1A receptors, and could be selectively targeted to enhance serotonergic neurotransmission.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Biochemistry & Molecular Biology

The 5-HT1A receptor: Signaling to behavior

Paul R. Albert, Faranak Vahid-Ansari

BIOCHIMIE (2019)

Editorial Material Neurosciences

Targeting Homer1a for Rapid Antidepressant Effects

Paul R. Albert

NEURON (2019)

Editorial Material Neurosciences

Orphans to the rescue: orphan G-protein coupled receptors as new antidepressant targets

Paul R. Albert

JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2020)

Article Psychiatry

Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression

Amin Zahrai, Faranak Vahid-Ansari, Mireille Daigle, Paul R. Albert

TRANSLATIONAL PSYCHIATRY (2020)

Review Clinical Neurology

Depression, dementia and immune dysregulation

Shawn Hayley, Antoine M. Hakim, Paul R. Albert

Summary: Major depression may be a precursor to cognitive decline and dementia, with chronic stress and inflammation compromising brain function and leading to depression and mild cognitive impairment. Treating inflammatory changes in depression can reverse the condition, and anti-inflammatory and antidepressant treatments may reduce or prevent dementia in individuals with depression. Chronic stress and inflammation may increase brain permeability and cytokine production, eventually manifesting as depression, cognitive impairment, and potentially dementia.
Editorial Material Neurosciences

Influence of functional gene polymorphisms on human behaviour: the case of CCR5

Paul R. Albert

JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2021)

Review Psychiatry

Rewiring of the Serotonin System in Major Depression

Faranak Vahid-Ansari, Paul R. Albert

Summary: Serotonin plays key roles in wiring the developing brain and synaptic reorganization during adulthood, mediated by 14 different 5-HT receptors. The 5-HT system has the capacity to regrow and reinnervate brain regions following insults, often leading to depression, anxiety, and cognitive impairment. Chronic treatment with antidepressants can accelerate the rewiring processes and potentially improve recovery from injury-induced mental illness or cognitive impairment.

FRONTIERS IN PSYCHIATRY (2021)

Editorial Material Neurosciences

A tribute to Dr. Ridha Joober

Paul R. Albert, Lena Palaniyappan, Patricia Boksa

JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2022)

Article Neurosciences

Mood disturbances in Parkinson's disease: From prodromal origins to application of animal models

S. Hayley, F. Vahid-Ansari, H. Sun, P. R. Albert

Summary: Parkinson's disease is a complex illness influenced by environmental factors and genetic vulnerability. Many studies focus on the disease's motor symptoms and overlook the debilitating non-motor features that occur early in the disease process. Comorbid psychiatric features, such as clinical depression, anxiety, and sleep disorders, are believed to emerge before prominent motor deficits. This review explores the prodromal stage of PD, the unfolding of early neuropsychiatric pathology, and later motor disturbances, as well as the complexity captured by animal models of PD.

NEUROBIOLOGY OF DISEASE (2023)

Meeting Abstract Neurosciences

Chronic desipramine induces norepinephrine projections to promote recovery in a mouse model of fluoxetine-resistant depression

Faranak Vahid-Ansari, Amin Zahrai, Mireille Daigle, Paul R. Albert

JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2022)

Meeting Abstract Neurosciences

Actions of acute and persistent optogenetic stimulation of serotonin neurons in a post-stroke depression mouse model

Min Zhang, Faranak Vahid-Ansari, Paul R. Albert

JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2022)

Meeting Abstract Clinical Neurology

FLUOXETINE-INDUCED 5-HTAXONAL PLASTICITY IN BEHAVIOURAL RECOVERY FOLLOWING UNILATERAL PREFRONTAL CORTICAL ISCHEMIA

F. Vahid-Ansari, A. Zahrai, P. Albert

INTERNATIONAL JOURNAL OF STROKE (2021)

Meeting Abstract Clinical Neurology

Chronic antidepressant fluoxetine enhances axonal plasticity associated with recovery from post-stroke depression phenotypes

Faranak Vahid-Ansari, Amin Zahrai, Paul Albert

INTERNATIONAL JOURNAL OF STROKE (2019)

Meeting Abstract Clinical Neurology

Direct serotonin system stimulation via optogenetics as treatment for post-stroke depression in a mouse model

Min Zhang, Faranak Vahid-Ansari, Paul Albert

INTERNATIONAL JOURNAL OF STROKE (2019)

Meeting Abstract Neurosciences

Chronic fluoxetine induces serotonin axonal plasticity in a poststroke depression model in mice.

Amin Zahrai, Faranak Vahid-Ansari, Paul R. Albert

JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2019)

暂无数据